KEQU

$34.90

Market ClosedAs of Mar 17, 8:00 PM UTC

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

AMZNTSLAHD

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$34.90
Potential Upside
129%
Whystock Fair Value$79.91
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorConsumer Cyclical
IndustryFurnishings, Fixtures & Appliances

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and woo...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$100.04M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
9.38
Beta
Defensive asset. Lower volatility than the S&P 500.
0.58
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
17.41%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.28

Recent News

Zacks
Mar 17, 2026

Kewaunee Earnings Decline Y/Y in Q3 Despite Sales Growth

KEQU posts modest sales growth in Q3 but a sharp profit decline, with domestic weakness offset partly by strong international performance.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 16, 2026

Kewaunee Scientific (NASDAQ:KEQU) Is Looking To Continue Growing Its Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 12, 2026

The Zacks Analyst Blog Highlights Eli Lilly, Marriott International, Fortinet, GSI Technology and Kewaunee Scientific

Eli Lilly, Marriott and Fortinet lead Zacks' top analyst picks after earnings beats and strong outlooks across pharma, travel and cybersecurity.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 11, 2026

Top Analyst Reports for Eli Lilly, Marriott & Fortinet

Eli Lilly's Q4 beat and soaring GLP-1 demand lead top analyst picks, alongside fresh insights on Marriott and Fortinet's latest results.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 26, 2026

Investors in Kewaunee Scientific (NASDAQ:KEQU) have seen strong returns of 207% over the past five years

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.